Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats.
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Propensity methods for multiple sclerosis: The devil is in the details.
Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
[Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].
The dynamics of mucosal-associated invariant T cells in multiple sclerosis.
Multiple sclerosis: Pregnancy and women's health issues.
Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility.
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Encephalomyelitis Associated With Dengue Fever.
Serum Vitamin B12 and thyroid hormone levels in Saudi patients with multiple sclerosis.
Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.
Peripheral neuropathies.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Fully-integrated framework for the segmentation and registration of the spinal cord white and gray matter.
Monoclonal Antibody Therapy for Neuromyelitis Optica Spectrum Disorder: Current and Future.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.
The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
Treatment of the osmotic demyelination syndrome: the earlier the better?
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Pages
« first
‹ previous
…
849
850
851
852
853
854
855
856
857
…
next ›
last »